Annual CAPEX
$9.96 M
-$20.76 M-67.58%
31 December 2023
Summary:
REGENXBIO annual capital expenditures is currently $9.96 million, with the most recent change of -$20.76 million (-67.58%) on 31 December 2023. During the last 3 years, it has fallen by -$16.91 million (-62.93%). RGNX annual CAPEX is now -88.17% below its all-time high of $84.17 million, reached on 31 December 2021.RGNX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$326.00 K
-$148.00 K-31.22%
30 September 2024
Summary:
REGENXBIO quarterly capital expenditures is currently $326.00 thousand, with the most recent change of -$148.00 thousand (-31.22%) on 30 September 2024. Over the past year, it has dropped by -$1.11 million (-77.35%). RGNX quarterly CAPEX is now -98.95% below its all-time high of $31.02 million, reached on 31 March 2021.RGNX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$2.48 M
-$1.11 M-30.95%
30 September 2024
Summary:
REGENXBIO TTM capital expenditures is currently $2.48 million, with the most recent change of -$1.11 million (-30.95%) on 30 September 2024. Over the past year, it has dropped by -$11.82 million (-82.64%). RGNX TTM CAPEX is now -97.05% below its all-time high of $84.17 million, reached on 31 December 2021.RGNX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGNX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -67.6% | -77.3% | -82.6% |
| 3 y3 years | -62.9% | -98.3% | -97.0% |
| 5 y5 years | -25.0% | -87.8% | -84.1% |
RGNX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -88.2% | at low | -98.3% | at low | -97.0% | at low |
| 5 y | 5 years | -88.2% | at low | -99.0% | at low | -97.0% | at low |
| alltime | all time | -88.2% | +1808.0% | -99.0% | +312.7% | -97.0% | +2242.4% |
REGENXBIO CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $326.00 K(-31.2%) | $2.48 M(-31.0%) |
| June 2024 | - | $474.00 K(-14.9%) | $3.60 M(-36.9%) |
| Mar 2024 | - | $557.00 K(-50.5%) | $5.70 M(-42.8%) |
| Dec 2023 | $9.96 M(-67.6%) | $1.13 M(-21.8%) | $9.96 M(-30.4%) |
| Sept 2023 | - | $1.44 M(-44.2%) | $14.30 M(-20.2%) |
| June 2023 | - | $2.58 M(-46.5%) | $17.91 M(-27.1%) |
| Mar 2023 | - | $4.82 M(-11.9%) | $24.57 M(-20.0%) |
| Dec 2022 | $30.72 M(-63.5%) | $5.47 M(+8.3%) | $30.72 M(-22.9%) |
| Sept 2022 | - | $5.05 M(-45.3%) | $39.87 M(-25.5%) |
| June 2022 | - | $9.24 M(-15.8%) | $53.52 M(-16.5%) |
| Mar 2022 | - | $10.97 M(-25.0%) | $64.12 M(-23.8%) |
| Dec 2021 | $84.17 M(+213.3%) | $14.61 M(-21.8%) | $84.17 M(+2.1%) |
| Sept 2021 | - | $18.70 M(-5.8%) | $82.45 M(+18.1%) |
| June 2021 | - | $19.84 M(-36.0%) | $69.82 M(+31.1%) |
| Mar 2021 | - | $31.02 M(+140.7%) | $53.26 M(+98.2%) |
| Dec 2020 | $26.87 M(+129.3%) | $12.89 M(+112.3%) | $26.87 M(+79.0%) |
| Sept 2020 | - | $6.07 M(+85.2%) | $15.01 M(+29.2%) |
| June 2020 | - | $3.28 M(-29.2%) | $11.62 M(-16.4%) |
| Mar 2020 | - | $4.63 M(+349.1%) | $13.89 M(+18.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $11.72 M(-11.7%) | $1.03 M(-61.5%) | $11.72 M(-24.8%) |
| Sept 2019 | - | $2.68 M(-51.8%) | $15.58 M(-4.3%) |
| June 2019 | - | $5.55 M(+126.3%) | $16.27 M(+21.5%) |
| Mar 2019 | - | $2.46 M(-49.8%) | $13.39 M(+0.8%) |
| Dec 2018 | $13.28 M(+85.4%) | $4.89 M(+45.0%) | $13.28 M(+26.6%) |
| Sept 2018 | - | $3.37 M(+26.2%) | $10.49 M(+38.6%) |
| June 2018 | - | $2.67 M(+14.0%) | $7.57 M(+15.1%) |
| Mar 2018 | - | $2.34 M(+11.6%) | $6.58 M(-8.2%) |
| Dec 2017 | $7.16 M(-12.1%) | $2.10 M(+366.9%) | $7.16 M(-24.6%) |
| Sept 2017 | - | $450.00 K(-73.2%) | $9.49 M(-15.7%) |
| June 2017 | - | $1.68 M(-42.6%) | $11.27 M(+5.7%) |
| Mar 2017 | - | $2.93 M(-34.0%) | $10.66 M(+30.8%) |
| Dec 2016 | $8.15 M(+1461.1%) | $4.43 M(+99.5%) | $8.15 M(+112.1%) |
| Sept 2016 | - | $2.22 M(+106.8%) | $3.84 M(+126.3%) |
| June 2016 | - | $1.07 M(+158.4%) | $1.70 M(+104.1%) |
| Mar 2016 | - | $416.00 K(+225.0%) | $832.00 K(+59.4%) |
| Dec 2015 | $522.00 K | $128.00 K(+62.0%) | $522.00 K(+32.5%) |
| Sept 2015 | - | $79.00 K(-62.2%) | $394.00 K(+25.1%) |
| June 2015 | - | $209.00 K(+97.2%) | $315.00 K(+197.2%) |
| Mar 2015 | - | $106.00 K | $106.00 K |
FAQ
- What is REGENXBIO annual capital expenditures?
- What is the all time high annual CAPEX for REGENXBIO?
- What is REGENXBIO annual CAPEX year-on-year change?
- What is REGENXBIO quarterly capital expenditures?
- What is the all time high quarterly CAPEX for REGENXBIO?
- What is REGENXBIO quarterly CAPEX year-on-year change?
- What is REGENXBIO TTM capital expenditures?
- What is the all time high TTM CAPEX for REGENXBIO?
- What is REGENXBIO TTM CAPEX year-on-year change?
What is REGENXBIO annual capital expenditures?
The current annual CAPEX of RGNX is $9.96 M
What is the all time high annual CAPEX for REGENXBIO?
REGENXBIO all-time high annual capital expenditures is $84.17 M
What is REGENXBIO annual CAPEX year-on-year change?
Over the past year, RGNX annual capital expenditures has changed by -$20.76 M (-67.58%)
What is REGENXBIO quarterly capital expenditures?
The current quarterly CAPEX of RGNX is $326.00 K
What is the all time high quarterly CAPEX for REGENXBIO?
REGENXBIO all-time high quarterly capital expenditures is $31.02 M
What is REGENXBIO quarterly CAPEX year-on-year change?
Over the past year, RGNX quarterly capital expenditures has changed by -$1.11 M (-77.35%)
What is REGENXBIO TTM capital expenditures?
The current TTM CAPEX of RGNX is $2.48 M
What is the all time high TTM CAPEX for REGENXBIO?
REGENXBIO all-time high TTM capital expenditures is $84.17 M
What is REGENXBIO TTM CAPEX year-on-year change?
Over the past year, RGNX TTM capital expenditures has changed by -$11.82 M (-82.64%)